This study evaluates the length of optic nerve lesion on 3D-DIR sequence as an imaging biomarker predictive of retinal axonal loss and visual disability, 12 months after the occurence of a first clinical episode of optic neuritis.
Neurologists and Neuro-Ophthalmologists are in need for reliable and robust imaging biomarkers enabling to predict retinal axonal loss and visual disability after clinical episode of optic neuritis (ON). Length of optic nerve lesion measured on MRI may be one of them. The aim of our study is to measure the association between the extent of inflammatory demyelinating process on optic nerve at the acute of ON and the retinal degenerative process following optic nerve injury. The investigators planned to include 50 patients suffering from a recent clinical episode of ON. Extent of demyelinating inflammatory process will be assessed by the length of optic nerve double inversion recovery (DIR) hypersignal at the acute phase of ON. The axonal degenerative process following optic nerve demyelinating injury will be assessed by retinal atrophy measured on optical coherence tomography at 12 months after ON, by visual disability measured on low vision contrast acuity scale and by microstructural quality analysis of optic nerve measured on diffusion tensor imaging sequence of the optic nerve.
Study Type
OBSERVATIONAL
Enrollment
46
Hôpital Roger Salengro, CHRU de Lille
Lille, France
Severity of retinal axonal loss around papilla after a clinical episode of optic neuritis
peripapillary RNFL thickness decrease
Time frame: 12 months
Severity of retinal axonal loss within macula after a clinical episode of optic neuritis
macular volume decrease
Time frame: 12 months
Severity of visual disability after a clinical episode of optic neuritis
monocular low contrast (2.5%) vision
Time frame: 12 months
Severity of microstructural architecture of optic nerve after a clinical episode of optic neuritis
fractional anisotropy
Time frame: 12 months
Progression of optic nerve lesion length
lesion length in mm measured on 3D-double inversion recovery sequence
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.